Delivery Order SPE2DR25D1109-SPE2DR26FFK3L
- Not listed
- The Defense Logistics Agency awarded a $6,257.14 delivery order to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on December 16, 2025, with a completion date of December 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $1,679.80 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Durolane 60 mg/3 ml syringes. This competitively awarded, firm fixed-price delivery order is expected to be completed by December 4, 2025, with fulfillment occurring at the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $18,044.80 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price contract, with a completion date of September 11, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $30,233.45 for Durolane 60 mg/3 mL syringes on January 5, 2026, with completion expected by January 6, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,495.41 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on December 11, 2025, with completion targeted for December 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's significantly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $10,514.15. This non-competitive, firm fixed-price delivery order is set to be completed by December 11, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,565.96 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on December 5, 2025, with a completion date of December 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's corporate headquarters location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $8,957.53. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 30, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,679.80 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on December 30, 2025, with performance completion targeted for December 31, 2025. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive selection through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a $3,187.90 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Durolane 60 mg/3 mL syringes. The contract, which is not set-aside and was competitively awarded, is classified as a firm fixed price delivery order with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFK3LDelivery Order
The Defense Logistics Agency awarded a $2,936.87 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Durolane 60 mg/3 ml syringes. This non-set-aside, competitively awarded contract reflects a firm fixed-price transaction with an ultimate completion date of January 9, 2026, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order operates as a child contract under Cencora, Inc., the parent pharmaceutical distribution company, which does business as AmerisourceBergen and maintains a significant presence in federal medical procurement. This delivery order is executed under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, medical devices, and healthcare commodities to support military healthcare programs and Defense Health Agency operations worldwide. The current task order for Durolane, a hyaluronic acid injection used primarily for osteoarthritis treatment, represents a routine fulfillment of the company's established pharmaceutical supply obligations to federal military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/7/26 |